Global Information, Inc. announced the immediate availability of a new report and new research tool for cancer drug research and development companies and market analysts: Oncology Drug Pathway Analyzer: Drug targets and their pathways are the critical link between drugs and their role in the treatment of cancer. The Oncology Drug Pathway Analyzer from BioSeeker Group AB is an interactive data tool to analyze thousands drug-pathway connections in close to 90 different cancer indications. This tool allows users to examine both single pathways and crosstalk between pathways of drugs and filter the included drugs per pathway by twelve drug specific parameters (that is Indication, Stage, Company, Molecular function etc.). With the Oncology Drug Pathway Analyzer, users can review their competition and find suitable benchmarking drugs, basing their search on specific pathways and drug properties. This will allow companies to uncover potential indication expansion areas for their drug portfolios, reveal repositioning opportunities for their older, shelved drugs, and evaluate the progression and success of targeting certain pathways for the treatment of cancer. This tool will also help users investigate different therapy combination options available for various cancer types, and reveal for the most-efficient ways to combine their drugs with other targeted agents.